Daiwa Securities Group Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
300.0%0.00%
Q2 2023$10.0%300.0%0.00%
Q1 2023$10.0%300.0%0.00%
Q4 2022$1
-99.9%
300.0%0.00%
Q3 2022$1,0000.0%300.0%0.00%
Q2 2022$1,0000.0%300.0%0.00%
Q1 2022$1,000
-50.0%
300.0%0.00%
Q4 2021$2,0000.0%300.0%0.00%
Q3 2021$2,000
+100.0%
300.0%0.00%
Q2 2021$1,0000.0%300.0%0.00%
Q1 2021$1,0000.0%300.0%0.00%
Q4 2020$1,000
-66.7%
30
-63.4%
0.00%
Q3 2020$3,000
-25.0%
820.0%0.00%
Q2 2020$4,0000.0%820.0%0.00%
Q1 2020$4,000
-20.0%
820.0%0.00%
Q4 2019$5,0000.0%820.0%0.00%
Q3 2019$5,0000.0%820.0%0.00%
Q2 2019$5,000
+25.0%
820.0%0.00%
Q1 2019$4,000
+33.3%
820.0%0.00%
Q4 2018$3,000
-50.0%
820.0%0.00%
Q3 2018$6,0000.0%820.0%0.00%
Q2 2018$6,000
+50.0%
820.0%0.00%
Q1 2018$4,000820.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
JW Asset Management, LLC 475,755$25,068,00024.71%
Hudson Executive Capital LP 971,000$51,162,00015.09%
Park West Asset Management LLC 1,051,274$55,392,0002.47%
U S GLOBAL INVESTORS INC 19,200$1,012,0000.62%
Capital Impact Advisors, LLC 26,317$1,387,0000.57%
CLARK ESTATES INC/NY 56,278$2,965,0000.47%
IRIDIAN ASSET MANAGEMENT LLC/CT 873,131$46,005,0000.41%
ProQuest Associates IV LLC 6,777$357,0000.41%
Granite Investment Partners, LLC 114,207$6,017,0000.40%
GLOBEFLEX CAPITAL L P 30,900$1,628,0000.34%
View complete list of EAGLE PHARMACEUTICALS INC shareholders